Unbearable Variability: What’s in Your CBD Gummy?
Cerium Journal Club -1st Tuesday of Every Month!
Time: December 1st, 12:00PM EST
Location – Virtual Meeting
https://us02web.zoom.us/j/83722922366?pwd=QjZ3V0xNWHZ0OVZ0b3BpbWd3STRqUT09
Are you getting what you paid for when you buy CBD gummies? A recent study suggests that the answer may be a little hard to swallow!
Join us as we chew over new research examining the accuracy, consistency, and cannabinoid content of commercially available CBD gummies. Using LC-MS/MS, researchers tested 56 products and found that 70% differed from their labeled CBD content by more than 10%, while 39% contained detectable THC. Even gummies from the same bottle sometimes contained substantially different amounts of cannabinoids.
We'll discuss what these findings mean for consumers, healthcare professionals, analytical laboratories, and regulators. How much variation is acceptable? What constitutes a reliable dose? And what does this research reveal about quality control in the rapidly growing cannabinoid marketplace?
Bring your questions, insights, and appetite for scientific discussion!
Featured Article
Johnson, E. D., et al. (2025). Cannabidiol Gummy Products: LC-MS/MS Assessment of Cannabinoid Concentrations.Cannabis and Cannabinoid Research, 10(6), 710–718.
https://doi.org/10.1089/can.2024.0167
Speakers
Phil Molloy, MD – Clinical education expert
Teresa Simon, MPH – Public health epidemiologist
Len Kamen, MD – Clinical pain specialist
Jahan Marcu, PhD – Cannabis researcher
Questions? Email: PRCtrials.info@gmail.com
This journal club is supported by PRC+.
PRC+ has education modules and resources available for healthcare professionals:
https://www.prc-trials-plus.com/education
Recordings can be view here:
https://www.youtube.com/@CeriumJournalClub